Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kesuting is a Traditional Chinese Medicine (TCM) syrup developed as a hospital preparation by The First Affiliated Hospital of Nanchang University. It is primarily indicated for the treatment of respiratory conditions characterized by cough and phlegm. During the COVID-19 pandemic, it was evaluated in clinical trials for its safety and efficacy in patients with mild to moderate COVID-19, often in conjunction with Keqing capsules. As a botanical formulation, its mechanism involves a complex interplay of phytochemicals that provide antitussive and anti-inflammatory effects to alleviate respiratory distress and sputum production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kesuting (First Affiliated Hospital of Nanchang University).